Human rotavirus vaccine (RIX4414) efficacy in the first two years of life-Reference-Cited by-同舟云学术

Human rotavirus vaccine (RIX4414) efficacy in the first two years of life

Published:2013-09-06 Issue:1 Volume:10 Page:11-18
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Li Rong-cheng,Huang Teng,Li Yan-Ping,Luo Dong,Tao Junhui,Fu Botao,Si Guoai,Nong Yi,Mo Zhao-Jun,Liao Xue-Yan,Luan Ivy,Tang Haiwen,Rathi Niraj,Karkada Naveen,Han Htay Htay

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.26319

Reference29 articles.

1. Rotavirus Overview

2. Update on Rotarix™: an oral human rotavirus vaccine

3. Global Mortality Associated with Rotavirus Disease among Children in 2004

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotype analysis of rotaviruses isolated from children during a phase III clinical trial with the hexavalent rotavirus vaccine in China;Virologica Sinica;2023-12

2. Application of the cell‐based RT‐qPCR assay (C‐QPA) for potency detection of the novel trivalent rotavirus vaccine in China;Journal of Clinical Laboratory Analysis;2023-11-17

3. Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants;Virologica Sinica;2022-10

4. Probiotic as Adjuvant Significantly Improves Protection of the Lanzhou Trivalent Rotavirus Vaccine against Heterologous Challenge in a Gnotobiotic Pig Model of Human Rotavirus Infection and Disease;Vaccines;2022-09-14

5. Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs;Human Vaccines & Immunotherapeutics;2022-07-11